This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fu, X X Articles by Rogler, C E Search for Related Content PubMed PubMed Citation Articles by Fu, X X Articles by Rogler, C E

 Previous Article  |  Next Article 

J Virol. 1988 September; 62(9): 3422-3430

Insulinlike growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers.

X X Fu, C Y Su, Y Lee, R Hintz, L Biempica, R Snyder and C E Rogler

Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461.

ABSTRACT

Insulinlike growth factor II (IGF-II) is a highly mitogenic fetal growth factor suspected of regulating the growth of a wide spectrum of tissues via an autocrine or paracrine mode of action or both. High steady-state levels of IGF-II RNA were detected in 45% of hepatocellular carcinomas (HCCs) arising from woodchuck livers with persistent woodchuck hepatitis virus (WHV) infection. Analysis of WHV RNA in the same HCCs revealed that HCCs with high levels of IGF-II RNA contained low or undetectable levels of WHV RNA and HCCs with low levels of IGF-II RNA contained high levels of WHV RNA. Integrated WHV DNA was present in HCCs from both groups, but viral DNA replicating forms were present, predominantly in HCCs with low levels of IGF-II. Several IGF-II RNAs, the most prominent of which were poly(A) species of approximately 3.75 and 1.1 to 1.3 kilobases, were detected only in precancerous nodules and HCCs. Levels of IGF-II were elevated two- to three-fold in the serum of woodchucks with chronic active hepatitis preceding the occurrence of HCC. Proliferation of a population of oval cells, which arise from portal tract regions in the liver, preceded the development of HCC and was a prominent feature of livers from which tumors with high levels of IGF-II occurred. The HCCs tended to have distinct histological features according to their growth factor status. Tumors with low levels of IGF-II were generally highly differentiated acinar-trabecular HCCs, whereas tumors with high levels of IGF-II were more anaplastic, with regions of fibrosis and fatty accumulation. A model to relate the pathology of WHV infection to oval cell proliferation and IGF-II expression in the development of these heterogeneous HCCs is presented.

---

J Virol. 1988 September; 62(9): 3422-3430

This article has been cited by other articles:

• Maronpot, R.R., Flake, G., Huff, A. J. (2004). Relevance of Animal Carcinogenesis Findings to Human Cancer Predictions and Prevention. Toxicol Pathol 32: 40-48 [Abstract]  
• SIMON, M.-T., PAULOIN, A., NORMAND, G., LIEU, H.-T., MOULY, H., PIVERT, G., CARNOT, F., TRALHAO, J. G., BRECHOT, C., CHRISTA, L. (2003). HIP/PAP stimulates liver regeneration after partial hepatectomy and combines mitogenic and anti-apoptotic functions through the PKA signaling pathway. FASEB J. 17: 1441-1450 [Abstract] [Full Text]  
• Birrer, R. B., Birrer, D., Klavins, J. V. (2003). Hepatocellular Carcinoma and Hepatitis Virus. Annals of Clinical & Laboratory Science 33: 39-54 [Abstract] [Full Text]  
• Lee, S., Tarn, C., Wang, W.-H., Chen, S., Hullinger, R. L., Andrisani, O. M. (2002). Hepatitis B Virus X Protein Differentially Regulates Cell Cycle Progression in X-transforming Versus Nontransforming Hepatocyte (AML12) Cell Lines. J. Biol. Chem. 277: 8730-8740 [Abstract] [Full Text]  
• Christa, L., Simon, M.-T., Brezault-Bonnet, C., Bonte, E., Carnot, F., Zylberberg, H., Franco, D., Capron, F., Roskams, T., Brechot, C. (1999). Hepatocarcinoma-Intestine-Pancreas/Pancreatic Associated Protein (HIP/PAP) Is Expressed and Secreted by Proliferating Ductules as well as by Hepatocarcinoma and Cholangiocarcinoma Cells. Am. J. Pathol. 155: 1525-1533 [Abstract] [Full Text]  
• Coste, A. d. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., Perret, C. (1998). Somatic mutations of the beta -catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 95: 8847-8851 [Abstract] [Full Text]  
• Wang, H.-P., Zhang, L., Dandri, M., Rogler, C. E. (1998). Antisense Downregulation of N-myc1 in Woodchuck Hepatoma Cells Reverses the Malignant Phenotype. J. Virol. 72: 2192-2198 [Abstract] [Full Text]  
• Trojan, J, Johnson, T., Rudin, S., Ilan, J, Tykocinski, M., Ilan, J (1993). Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 259: 94-97 [Abstract]